We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CapitalBio Corporation Certified to Provide NimbleGen Array Services in China
News

CapitalBio Corporation Certified to Provide NimbleGen Array Services in China

CapitalBio Corporation Certified to Provide NimbleGen Array Services in China
News

CapitalBio Corporation Certified to Provide NimbleGen Array Services in China

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "CapitalBio Corporation Certified to Provide NimbleGen Array Services in China"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Roche NimbleGen has announced that Beijing-based genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

CapitalBio has been certified to process customer samples for NimbleGen Gene Expression, Comparative Genomic Hybridization/Copy Number Variation (CGH/CNV), and DNA Methylation services in their lab in Beijing, China and is the first NimbleGen CSP in Asia to implement the MS 200 Microarray Scanner into their array workflow for high-resolution scanning. CapitalBio brings six years experience of genetic research services to the Chinese scientific community, which was instrumental in their certification as a service provider.

“The launch of the Roche NimbleGen CSP Program at CapitalBio represents a major step forward in our efforts to bring advanced DNA analysis to China” said Junquan XU, Vice President of Operations at CapitalBio.

“We will now be able to expand our service to customers through access of the complete NimbleGen Single-Color (Gene Expression) or Dual-Color (CGH/CNV & DNA Methylation) workflow. We are pleased to have passed the rigorous certification procedures and experimental standards to become part of the Roche NimbleGen CSP Program,” XU said.
Advertisement